Epidemiology Practice Questions

Q: Which of the following is NOT true about cohort studies?

They are useful for rare diseases.. **Explanation:** In epidemiology, a **Cohort Study** is an observational analytical study that starts with a group of exposed and non-exposed individuals and follows them forward in time to see who develops the disease. **Why Option B is the correct answer (NOT true):** Cohort studies are **not** suitable for rare diseases. Because these studies follow people over time to see if they develop a condition, if the disease is rare (e.g., a specific rare cancer), the researcher would need to follow an impractically large population for a very long duration to observe even a few cases. **Case-control studies** are the preferred design for rare diseases as they start with people who already have the condition. **Analysis of Incorrect Options:** * **Option A (They are prospective):** This is true. Most cohort studies move forward from cause to effect. (Note: Retrospective cohorts exist but the logic remains "exposure to outcome"). * **Option C (Necessary for calculating incidence):** This is true. Since we start with a disease-free population and monitor new cases over time, cohort studies are the only observational design that directly calculates **Incidence** and **Relative Risk (RR)**. * **Option D (They are costly):** This is true. Due to long follow-up periods, large sample sizes, and the need for repeated testing/staffing, they are significantly more expensive than cross-sectional or case-control studies. **High-Yield NEET-PG Pearls:** * **Direction:** Forward (Exposure $\rightarrow$ Outcome). * **Best for:** Rare **exposures** (e.g., occupational hazards). * **Key Metric:** Relative Risk (RR) and Attributable Risk (AR). * **Major Bias:** Selection bias and **Attrition bias** (loss to follow-up). * **Mnemonic:** "C"ohort = "C"ause to effect; "C"alculates In"c"idence.

Q: Which of the following is best to compare the vital statistics of countries?

Age standardized death rate. **Explanation** The **Age Standardized Death Rate (ASDR)** is the gold standard for comparing the health status and vital statistics of different populations. This is because age is the most significant determinant of mortality; a population with a higher proportion of elderly individuals will naturally have more deaths than a younger population, even if health services are superior. Standardization (Direct or Indirect) removes the confounding effect of different age structures, allowing for a "fair" or "apples-to-apples" comparison between countries. **Why other options are incorrect:** * **Crude Death and Birth Rates:** These are influenced heavily by the age and sex composition of the population. A developed country with an aging population may have a higher crude death rate than a developing country with a young population, which is misleading. * **Proportional Mortality Rate:** This measures the proportion of total deaths due to a specific cause (e.g., CVD). It does not reflect the actual risk of dying in a population and is used to identify the relative importance of a disease within a group, not for cross-country comparison. * **Age-Specific Death Rate:** While accurate for a specific age group (e.g., 5–10 years), it only provides a partial picture. It cannot be used to compare the overall health status of entire nations without being integrated into a standardized index. **High-Yield Pearls for NEET-PG:** * **Standardized Mortality Ratio (SMR):** Used in indirect standardization; it is the ratio of Observed Deaths to Expected Deaths. * **Indicator of Choice:** While ASDR is best for comparison, the **Infant Mortality Rate (IMR)** is considered the most sensitive indicator of a country’s overall health status and socio-economic development. * **Life Expectancy at Birth:** The best single indicator of the "level of living" and overall health of a population.

Q: What determines the diagnostic accuracy of a test?

Predictive value. **Explanation:** The **Predictive Value** (Positive and Negative) is the most clinically relevant measure of diagnostic accuracy because it determines the probability that a test result correctly reflects the true disease status of an individual patient. While sensitivity and specificity are inherent properties of the test itself, the predictive value tells a clinician how much they can trust a result in a real-world setting. * **Why Predictive Value is correct:** Diagnostic accuracy in a clinical context refers to the test's ability to correctly identify diseased and non-diseased individuals within a population. Predictive values are influenced by the **prevalence** of the disease. A test with high sensitivity is useless if its Positive Predictive Value (PPV) is low due to low disease prevalence, as most "positives" would be false alarms. * **Why Sensitivity is incorrect:** Sensitivity measures the ability of a test to correctly identify those *with* the disease (True Positive Rate). It is used for screening (SNOUT) but does not account for false positives, thus it cannot alone define overall diagnostic accuracy. * **Why Specificity is incorrect:** Specificity measures the ability to correctly identify those *without* the disease (True Negative Rate). It is used for confirmation (SPIN) but does not account for false negatives. **High-Yield Clinical Pearls for NEET-PG:** 1. **Prevalence Relationship:** If prevalence increases, **PPV increases** and **NPV decreases**. Sensitivity and Specificity remain unchanged. 2. **Screening vs. Diagnosis:** Use a high-sensitivity test to "Rule Out" (Screening) and a high-specificity test to "Rule In" (Diagnosis). 3. **Likelihood Ratio:** This is considered the best tool for measuring diagnostic accuracy independent of prevalence, but among the given options, Predictive Value is the standard clinical measure.

Q: Which Indian state has a crude birth rate higher than the national average?

Rajasthan. **Explanation:** The **Crude Birth Rate (CBR)** is defined as the number of live births per 1,000 mid-year population in a given year. It is a sensitive indicator of fertility levels and population growth. According to the latest **Sample Registration System (SRS) Bulletin**, the national average CBR for India stands at approximately **19.5 per 1,000 population**. **Why Rajasthan is Correct:** Rajasthan consistently reports a CBR (approx. **23.5**) significantly higher than the national average. This is attributed to a higher Total Fertility Rate (TFR), lower contraceptive prevalence in rural pockets, and socio-demographic factors prevalent in the "BIMARU" states (Bihar, Madhya Pradesh, Rajasthan, and Uttar Pradesh), all of which typically exceed national fertility benchmarks. **Analysis of Incorrect Options:** * **West Bengal:** Has successfully transitioned to a low CBR (approx. **14.2**), well below the national average, due to effective family welfare programs. * **Maharashtra:** As a more urbanized and socio-economically advanced state, its CBR (approx. **15.3**) remains lower than the national mean. * **Andhra Pradesh:** One of the first southern states to achieve replacement-level fertility; its CBR (approx. **15.9**) is significantly lower than the national average. **High-Yield Pearls for NEET-PG:** * **Highest CBR in India:** Bihar (approx. 25.5). * **Lowest CBR in India:** Kerala / Andaman & Nicobar Islands. * **Replacement Level Fertility (TFR):** 2.1 (India’s current TFR has reached 2.0 as per NFHS-5). * **CBR Formula:** (Number of live births during the year / Mid-year population) × 1000.

Q: Point prevalence studies tend to overestimate the occurrence of which of the following diseases?

Diseases with a long duration. **Explanation** The correct answer is **B. Diseases with a long duration.** **Understanding the Concept** Prevalence is defined by the formula: **Prevalence (P) ≈ Incidence (I) × Duration (D)**. Point prevalence acts like a "snapshot" in time. Because diseases with a long duration (chronic conditions) stay in the population pool for an extended period, they are much more likely to be captured during a single point-in-time survey. Conversely, diseases that resolve quickly (either through cure or death) are often missed by such snapshots, leading to an over-representation of chronic cases in prevalence data. This is known as **Neyman bias** (or length-time bias). **Analysis of Incorrect Options** * **A. Diseases with a high incidence:** Incidence refers to new cases. A disease can have high incidence but very short duration (e.g., Common Cold); in such cases, point prevalence remains low because patients recover quickly. * **C. Diseases with a high mortality:** High mortality reduces the duration of the disease. If a patient dies quickly after onset, they are less likely to be "present" in the population when a prevalence study is conducted. * **D. Diseases with a short duration:** These are underestimated by point prevalence studies because the "window of opportunity" to identify the case is very small. **NEET-PG High-Yield Pearls** * **Incidence** is the best indicator for the **etiology** of a disease and the efficacy of prevention programs. * **Prevalence** is the best indicator for **administrative planning** and estimating the burden of chronic diseases. * Prevalence **increases** with: Longer duration, prolongation of life without cure, and in-migration of cases. * Prevalence **decreases** with: High fatality rates, shorter duration, and improved cure rates.

Q: Which of the following are modes of cholera transmission?

Healthy carrier. **Explanation:** Cholera, caused by *Vibrio cholerae*, is primarily transmitted through the **fecal-oral route**. In the context of epidemiology, the **Healthy Carrier** plays a critical role in transmission. These are individuals who harbor the pathogen and can excrete it in their stools for 7–14 days but do not manifest clinical symptoms. Because they are asymptomatic, they move freely in the community, serving as a silent reservoir and a major source of environmental contamination. **Analysis of Options:** * **Healthy Carrier (Correct):** In cholera, for every one severe clinical case, there are approximately 50–100 asymptomatic (healthy) carriers (for El Tor biotype). They are the main "propagators" of an epidemic. * **Food transmission:** While cholera is transmitted via contaminated food and water, the question asks for the *mode* or *source* characteristic. Between a general vehicle (food) and a specific epidemiological reservoir (carrier), the carrier status is a more specific "mode" of maintaining the infection chain in a population. * **Vaccination efficiency:** Current oral cholera vaccines (OCVs) like Shanchol or Dukoral provide roughly 50–65% protection over 3–5 years, not 90%. * **Chlorination:** This is actually the most effective method for disinfecting water against *V. cholerae*. A free residual chlorine level of 0.5 mg/L is highly effective. **NEET-PG High-Yield Pearls:** * **Reservoir:** Man is the only known reservoir. * **Case-to-Carrier Ratio:** 1:10 for Classical cholera; 1:50 to 1:100 for El Tor. * **Incubation Period:** Very short (1–5 days), leading to "explosive" epidemics. * **Gold Standard Diagnosis:** Stool culture on **TCBS medium** (Thiosulfate Citrate Bile Salts Sucrose). * **Stool Appearance:** "Rice water stools" with a fishy odor.

Question 1

Which of the following is NOT true about cohort studies?

Accepted Answer

They are useful for rare diseases.

Answer

They are prospective.

Answer

They are necessary for calculating incidence.

Answer

They are costly.

Question 2

Maternal mortality rate is expressed as:

Accepted Answer

100,000 live births

Answer

1000 live births

Answer

1000 pregnancies

Answer

100 pregnancies

Question 3

Which of the following is best to compare the vital statistics of countries?

Accepted Answer

Age standardized death rate

Answer

Crude death and birth rates

Answer

Proportional mortality rate

Answer

Age specific death rate

Question 4

What determines the diagnostic accuracy of a test?

Accepted Answer

Predictive value

Answer

Sensitivity

Answer

Specificity

Answer

None of the above

Question 5

Which Indian state has a crude birth rate higher than the national average?

Accepted Answer

Rajasthan

Answer

West Bengal

Answer

Maharashtra

Answer

Andhra Pradesh

Question 6

According to the latest WHO classification and measurement of disability, what is the correct terminology?

Accepted Answer

ICD

Answer

IDEAS

Answer

ICIDH-II

Answer

WHO DAS I

Question 7

According to epidemiological studies, which dietary factor has been found to be most protective against carcinoma of the colon?

Accepted Answer

High fiber diet

Answer

Low fat diet

Answer

Low selenium diet

Answer

Low protein diet

Question 8

Point prevalence studies tend to overestimate the occurrence of which of the following diseases?

Accepted Answer

Diseases with a long duration

Answer

Diseases with a high incidence

Answer

Diseases with a high mortality

Answer

Diseases with a short duration

Question 9

What is the definition of relative risk?

Accepted Answer

Incidence of disease among the exposed divided by the incidence of disease among the non-exposed

Answer

Incidence of disease among the exposed minus the incidence of disease among the non-exposed

Answer

Incidence of disease among the exposed plus the incidence of disease among the non-exposed

Answer

None of the above

Question 10

Which of the following are modes of cholera transmission?

Accepted Answer

Healthy carrier

Answer

Food transmission

Answer

Vaccination gives 90% efficiency

Answer

Chlorination is not effective

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?